Onset-hastened/enhanced analgesia

Details Onset-hastened/enhanced analgesia Onset-hastened/enhanced analgesia

1987-11-17

1989-11-28

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

514571, A61K 3119

Patent

active

048838187

ABSTRACT:
Onset-hastened and enhanced analgesic response is elicited in a mammalian organism in need of such treatment, i.e., a mammal suffering pain, by administering thereto a unit dosage onset-hastening/enhancing analgesically effective amount of the S(+) fenoprofen enantiomer, said enantiomer being substantially free of its R(-) fenoprofen antipode.

REFERENCES:
patent: 3600437 (1971-08-01), Marshall
patent: 3637767 (1972-01-01), Alvarez
patent: 4440787 (1984-04-01), de Vincentiis
patent: 4464376 (1984-08-01), Sunshine et al.
patent: 4501727 (1985-02-01), Armitage et al.
patent: 4542237 (1985-09-01), Schloemer
patent: 4552899 (1985-11-01), Sunshine et al.
patent: 4558051 (1985-12-01), Sunshine et al.
patent: 4619934 (1986-10-01), Sunshine et al.
patent: 4722938 (1988-02-01), Sunshine et al.
"Stereoselective Inversion of (R)-Fenoprofen to (S)-Fenoprofen in Humans", Journal of Pharmaceutical Sciences, A. Rubin et al., vol. 74, No. 1, Jan. 1985, pp. 82-84.
"Importance of Drug Enantiomers in Clinical Pharmacology", Drugs, Kenneth Williams et al., vol. 30 (1985), pp. 333-354.
"Enantioselective Disposition of 2-Arylpropionic Acid Nonsteroidal Anti-Inflammatory Drugs. III. Fenoprofen Disposition", The Journal of Pharmacology and Experimental Therapeutics, P. J. Hayball et al., vol. 240, No. 2 (1987), pp. 631-636.
"Isomeric Inversion of Ibuprofen (R)-Enantiomer in Humans", Journal of Pharmaceutical Sciences, D. G. Kaiser et al., vol. 65, No. 2, Feb. 1976, pp. 269-273.
"Enantiospecific High-Performance Liquid Chromatographic Analysis of 2-Phenylpropionic Acid, Ketoprofen and Fenoprofen", Journal of Chromatography, B. C. Sallustio et al., vol. 374 (1986), pp. 329-337.
"The Metabolic Chiral Inversion of 2-Arylpropionic Acids--A Novel Route with Pharmacological Consequences", J. Pharm. Pharmacol., Andrew J. Hutt et al., vol. 35 (1983), pp. 693-704.
"The Importance of Stereochemistry in the Clinical Pharmacokinetics of the 2-Arylpropionic Acid Non-Steroidal Anti-Inflammatory Drugs", Clinical Pharmacokinetics, Andrew J. Hutt et al., vol. 9 (1984), pp. 371-375.
"Naproxen", Anti-Inflammatory and Anti-Rheumatic Drugs, Anthony C. Allison, et al., vol. 11, Chapter 9, Ed.: K. D. Rainsford, CRC Press, Inc., Boca Raton, Florida, p. 172.
"Gas Chromatographic Separation of Optically Active Anti-Inflammatory 2-Arylapropionic Acids Using (+)- or (-)-Amphetamine as Derivatizing Reagent", J. Chromatogr. Biomed. Appl., N. N. Singh, et al., vol. 378, No. 1 (1986), pp. 125-135.
"The Resolution of Enantiomeric Drugs Using HPLC Chiral Stationary Phases", Pharm. Technol., T. D. Doyle et al., vol. 9, No. 2 (1985), pp. 28-32.
"Application of High-Performance Liquid Chromatographic Chiral Stationary Phases to Pharmaceutical Analysis: Structural and Conformational Effects in the Direct Enantiomeric Resolution of Alpha Methylarylacetic Acid Antiinflammatory Agents", J. Chromatogr., I. W. Wainer, et al., vol. 284, No. 1 (1984), pp. 117-124.
Physician's Desk Reference, 41st Edition (1987), Publisher: Edward A. Barnhart, Medical Economics Company, Inc., Oradell, N.J. 07649, pp. 890-891.

Affiliated with

Also associated with

Rating

Onset-hastened/enhanced analgesia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Onset-hastened/enhanced analgesia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Onset-hastened/enhanced analgesia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-582351